outstanding results ., page-10

Any chance of a long term US partnership @suzuki42?

I can think of one or two US firms who may be worth a phone call.... partner would be able to run an old school protection racket on the share price while we dual list in the US, build up a customer base and then take out both of the majors within 2-5 years.

Would avoid anti-trust concerns because market share is currently non-existent and FDA would be happy as its a US listed entity with a globally superior product, (maybe throw in some US manufacturing into the mix) and get the US insurers onboard as the costs would plummet on there end due to superior durability and no need for surgery costs to replace inferior valves

Just a thought, no doubt this would have been raised/ addressed behind closed doors but has always been on my mind